-
INBS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Intelligent Bio Solutions (INBS)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jun 24 | Jun 23 | Jun 22 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 3.99 mm | 3.99 mm | 3.99 mm | 3.99 mm | 3.99 mm | 3.99 mm |
Cash burn (monthly) | 771.56 k | (no burn) | 908.42 k | 873.51 k | 795.74 k | 887.25 k |
Cash used (since last report) | 3.11 mm | n/a | 3.66 mm | 3.52 mm | 3.20 mm | 3.57 mm |
Cash remaining | 884.40 k | n/a | 333.61 k | 474.12 k | 787.08 k | 418.82 k |
Runway (months of cash) | 1.1 | n/a | 0.4 | 0.5 | 1.0 | 0.5 |
13F holders | Current |
---|---|
Total holders | 13 |
Opened positions | 9 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 607.20 mm |
Total shares | 1.21 mm |
Total puts | 0.00 |
Total calls | 222.91 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Lind Global Fund II | 386.00 k | $170.00 k |
Gary W. Rollins Foundation | 213.27 k | $595.00 k |
IOI Ionic Ventures | 148.50 k | $443.00 k |
Bigger Capital Fund L P | 144.50 k | $149.00 k |
ADAR1 Capital Management | 108.25 k | $207.84 mm |
Altium Capital Management | 83.91 k | $161.10 mm |
CVI | 79.84 k | $153.30 mm |
Geode Capital Management | 19.06 k | $36.59 mm |
Vanguard | 15.49 k | $29.73 mm |
UBS UBS | 8.32 k | $15.97 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Sep 24 | Harry Simeonidis | Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 40,408 |
25 Sep 24 | Spiro Kevin Sakiris | Common Stock | Grant | Acquire A | No | No | 0 | 34,500 | 0.00 | 34,815 |
20 Mar 24 | Spiro Kevin Sakiris | Common Stock | Acquire X | Yes | No | 0 | 9,394 | 0.00 | 19,180 | |
20 Mar 24 | Spiro Kevin Sakiris | Common Stock Warrants (Series F) Common Stock | Dispose X | Yes | No | 0 | 9,394 | 0.00 | 0 | |
4 Oct 23 | Spiro Kevin Sakiris | Common Stock | Buy | Acquire P | Yes | No | 0 | 112,727 | 0.00 | 117,427 |
4 Oct 23 | Spiro Kevin Sakiris | Common Stock Warrants (Series F) Common Stock | Buy | Acquire P | Yes | No | 0 | 112,727 | 0.00 | 112,727 |
4 Oct 23 | Spiro Kevin Sakiris | Common Stock Warrants (Series E) Common Stock | Buy | Acquire P | Yes | No | 0 | 112,727 | 0.00 | 112,727 |